| Name | Title | Contact Details |
|---|
CliniQAl Consult Corporation is a North York, ON-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Portola Pharmaceuticals is dedicated to developing and commercializing therapies that transform patient lives and advance patient care by changing treatment paradigms in thrombosis and other hematologic diseases. Our two lead assets are Bevyxxa® (betrixaban), and andexanet alfa. In addition, cerdulatinib is our investigational Syk/JAK inhibitor to treat hematologic cancers. These compounds come from our own internal research efforts and represent important advances to address significant unmet needs. We are employing novel strategies that may increase the likelihood of clinical, regulatory and commercial success of our potentially lifesaving therapies.
Ascendis Pharma is focused on creating drug candidates that are improved versions of existing drugs, yielding more effective, lower-risk drugs with new patent life. Our proprietary TransCon platform is the leading, most versatile transient conjugation technology and is utilized to create clinically superior prodrugs in therapeutic areas characterized by high unmet medical need. TransCon technology creates novel long acting prodrugs of proteins, peptides and small molecules, suitable for either local or systemic treatment. Ascendis Pharma has a diversified and balanced high-value pipeline, including internal programs and partnerships together with market leaders on their key projects.
RelayHealth Corporation is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in Atlanta, GA. To find more information about RelayHealth Corporation, please visit www.relayhealth.com
Fox Subacute Center is a Warrington, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.